Literature DB >> 3519830

Experimental systemic amyloidosis induced by immunization with syngeneic organ extracts in mice.

Y Mori, B Akikusa, T Mori, S Ueda, K Iesato, H Yoshida, M Ogawa, I Kato, Y Wakashin, M Wakashin.   

Abstract

Systemic amyloidosis was induced consistently in mice by intramuscular injection of syngeneic organ (liver and kidney) extracts mixed with CFA six times at weekly intervals. Syngeneic organ extract with CFA also induced amyloidosis of a lesser degree. All three strains of mice (C57BL/6, C3H/He, and BALB/c) injected with a syngeneic liver extract mixed with CFA developed systemic amyloidosis; the most prominent amyloid deposition occurred in C57BL/6 (B6) mice, followed by C3H/He and BALB/c. The amyloid substance deposited in these animals was identified as mouse amyloid A protein (AA). Furthermore, an organ specificity of the immunogen in inducing amyloidosis was suggested with liver and kidney extracts. Primed spleen cells of the immunized B6 mice were fractionated by a nylon-wool column and injected to normal recipient mice via the tail vein. Organs of the recipient mice developed systemic amyloidosis 8 wk after the transfer, and the most prominent histological changes occurred in the recipient mice given nylon-wool column adherent spleen cells. Using anti-Thy-1,2; Ly-1; Ly-2, antibody and complement, it was suggested that T cells, especially Ly-1,2,3+ T cell populations in the primed nylon-wool adherent cells, play an important role in the induction of systemic amyloidosis. It was shown further that the amyloidosis-inducing substance in liver extract was composed of unstable proteins or protein-bound substance.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3519830      PMCID: PMC2188133          DOI: 10.1084/jem.163.6.1553

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  26 in total

1.  Transfer amyloidosis.

Authors:  F Hardt; P Ranlov
Journal:  Int Rev Exp Pathol       Date:  1976

2.  Some factors in the development, localization and reabsorption of experimental amyloidosis in the rabbit.

Authors:  G F Dick; L Leiter
Journal:  Am J Pathol       Date:  1941-09       Impact factor: 4.307

3.  Murine amyloidosis: immunologic characterization of amyloid fibril protein.

Authors:  C Isersky; D L Page; P Cuatrecasas; R A DeLellis; G G Glenner
Journal:  J Immunol       Date:  1971-12       Impact factor: 5.422

4.  Quantitative studies on the T cell populations in spleens from amyloidotic and non-amyloidotic mice.

Authors:  F Hardt; M H Claësson
Journal:  Immunology       Date:  1972-04       Impact factor: 7.397

5.  Different regulatory mechanisms for serum amyloid A and serum amyloid P synthesis by cultured mouse hepatocytes.

Authors:  E Tatsuta; J D Sipe; T Shirahama; M Skinner; A S Cohen
Journal:  J Biol Chem       Date:  1983-05-10       Impact factor: 5.157

6.  Synthesis and secretion of serum amyloid protein A (SAA) by hepatocytes in mice treated with casein.

Authors:  M D Benson; E Kleiner
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

7.  Casein-induced experimental amyloidosis. V. The response of lymphoid organs to T and B mitogens.

Authors:  M A Scheinberg; M Bennett; E S Cathcart
Journal:  Lab Invest       Date:  1975-07       Impact factor: 5.662

8.  Amyloid-related serum protein SAA in endotoxin-induced amyloidosis of the mink.

Authors:  R F Anders; K Nordstoga; J B Natvig; G Husby
Journal:  J Exp Med       Date:  1976-03-01       Impact factor: 14.307

9.  Murine model for human secondary amyloidosis: genetic variability of the acute-phase serum protein SAA response to endotoxins and casein.

Authors:  K P McAdam; J D Sipe
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

10.  Impaired Kupffer cell function precedes development of secondary amyloidosis.

Authors:  A Fuks; D Zucker-Franklin
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.